American International Group, Inc. Biovie Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.53 - $1.89 $236 - $844	447 Added 7.44%	6,454 $3,000
Q4 2023 Feb 13, 2024	BUY	$1.22 - $5.24 $5,307 - $22,794	4,350 Added 262.52%	6,007 $7,000
Q3 2023 Nov 13, 2023	BUY	$2.75 - $5.17 $162 - $305	59 Added 3.69%	1,657 $5,000
Q2 2023 Aug 04, 2023	BUY	$4.09 - $8.29 $6,535 - $13,247	1,598 New	1,598 $6,000

340K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $97.1M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.